Gyre Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $145.9M
Liabilities Breakdown FY2013
Total Liabilities: $11.3M
Asset Breakdown
Total Assets: $145.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.8M | 1.9% |
| Accounts Receivable | $278.0K | 0.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $682.0K | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $97.0K | 0.1% |
| Other Assets | $142.0M | 97.3% |
Liabilities Breakdown
Total Liabilities: $11.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.3M | 11.5% |
| Long-Term Debt | $283.0K | 2.5% |
| Other Liabilities | $9.7M | 86.0% |